SEC Form 4 · accession 0001406618-18-000003
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey G Park
Director
Period of report
May 23, 2018
Accepted (ET)
May 25, 2018 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | May 23, 2018 | S | 13,875 | $24.2022 | D | 41,448 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1(1) The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the delivery of shares of common stock from previously awarded Restricted Stock Units.
- F2(2) The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $24.025 to $24.29 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
- F3(3) Number of securities in this column gives effect to the forfeiture of 21,666 shares underlying RSUs since the reporting persons most recent filing, as certain vesting conditions were not met.